Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000919574-23-003717
Filing Date
2023-06-15
Accepted
2023-06-15 16:31:40
Documents
1

Document Format Files

Seq Description Document Type Size
1 d10654143_13-g.htm SC 13G 109152
  Complete submission text file 0000919574-23-003717.txt   110780
Mailing Address 540 MADISON AVENUE 7TH FLOOR NEW YORK NY 10022
Business Address 540 MADISON AVENUE 7TH FLOOR NEW YORK NY 10022 2127025204
SUVRETTA CAPITAL MANAGEMENT, LLC (Filed by) CIK: 0001569064 (see all company filings)

EIN.: 453704500 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 4225 EXECUTIVE SQUARE SUITE 600 LA JOLLA CA 92037
Business Address 4225 EXECUTIVE SQUARE SUITE 600 LA JOLLA CA 92037 858-247-0520
Zura Bio Ltd (Subject) CIK: 0001855644 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-92696 | Film No.: 231017838
SIC: 2836 Biological Products, (No Diagnostic Substances)